United States Lidocaine Patches Market - Top Companies and Manufacturers

U.S. Lidocaine Patch Market

Introduction
1. Study Objective
2. Scope of the report
3. Market Taxonomy
Study Assumptions and Abbreviations
1. Research Methodology
2. Secondary Research
3. Primary Research
4. SPSS Approach
5. Data Triangulation
Executive Summary
U.S. Industry Overview
1. Market Overview
2. Industry Supply Chain Analysis
3. DROTs
  1. Driver
  2. Restraint
  3. Opportunities
  4. Trends
4. Government Regulation: How they would Aid the Business?
5. Competitive Landscape
  1. Amneal Pharmaceuticals LLC
  2. Endo Pharmaceuticals Inc
  3. Hisamitsu America, Inc.
  4. Medline Industries, LP.
  5. Scilex Pharmaceuticals Inc.
  6. Sparsha Pharma USA
  7. Teikoku Pharma
  8. Teva Pharmaceuticals USA, Inc.
  9. Viatris Inc.
  10. YARAL Pharma Inc.
6. Technology Analysis
7. Reimbursement Trends in the Lidocaine Patches Industry
8. Startup Analysis
9. Ongoing Technological Advancements
10. SWOT Analysis
11. Price Benchmarking
12. Pain Patch Market: Key Products And Future Outlook
13. Strategic Pathways For Success in the US Lidocaine Patches Market
14. Pipeline Analysis of Lidocaine Patches in the US
15. Epidemiological Overview Of Diseases Treated With Lidocaine Patches
16. Wholesale Acquisition Cost Sale Analysis
17. Factors Influencing The Price Changes
18. Root Cause Analysis
19. PESTLE Analysis
20. Porter Five Forces Analysis
21. Industry Risk
U.S. Outlook and Projections
1. Overview
  1. Market Value (USD Million), Volume (Million Units) and Current and Future Projections, 2024-2034
  2. Increment $ Opportunity Assessment, 2024-2034
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), 2024-2034, By
  1. Type, Value (USD Million), Volume (Million Units)
    1. Prescription Medicines
    2. OTC Medicines
  2. End user, Value (USD Million)
    1. Hospital Pharmacies
    2. Drug Stores and Retail Pharmacies
    3. Online Providers
  3. Region, Value (USD million)
    1. Northeast
    2. Southeast
    3. Midwest
    4. Southwest
    5. West
Northeast Market
1. Overview
  1. Market Value (USD Million), Volume (Million Units) and Current and Future Projections, 2024-2034
  2. Increment $ Opportunity Assessment, 2024-2034
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), 2024-2034, By
  1. Type, Value (USD Million), Volume (Million Units)
    1. Prescription Medicines
    2. OTC Medicines
  2. End user, Value (USD Million)
    1. Hospital Pharmacies
    2. Drug Stores and Retail Pharmacies
    3. Online Providers
Southeast Market
1. Overview
  1. Market Value (USD Million), Volume (Million Units) and Current and Future Projections, 2024-2034
  2. Increment $ Opportunity Assessment, 2024-2034
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), 2024-2034, By
  1. Type, Value (USD Million), Volume (Million Units)
    1. Prescription Medicines
    2. OTC Medicines
  2. End user, Value (USD Million)
    1. Hospital Pharmacies
    2. Drug Stores and Retail Pharmacies
    3. Online Providers
Midwest Market
1. Overview
  1. Market Value (USD Million), Volume (Million Units) and Current and Future Projections, 2024-2034
  2. Increment $ Opportunity Assessment, 2024-2034
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), 2024-2034, By
  1. Type, Value (USD Million), Volume (Million Units)
    1. Prescription Medicines
    2. OTC Medicines
  2. End user, Value (USD Million)
    1. Hospital Pharmacies
    2. Drug Stores and Retail Pharmacies
    3. Online Providers
Southwest Market
1. Overview
  1. Market Value (USD Million), Volume (Million Units) and Current and Future Projections, 2024-2034
  2. Increment $ Opportunity Assessment, 2024-2034
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), By
  1. Type, Value (USD Million), Volume (Million Units)
    1. Prescription Medicines
    2. OTC Medicines
  2. End user, Value (USD Million)
    1. Hospital Pharmacies
    2. Drug Stores and Retail Pharmacies
    3. Online Providers
West Market
1. Overview
  1. Market Value (USD Million), Volume (Million Units) and Current and Future Projections, 2024-2034
  2. Increment $ Opportunity Assessment, 2024-2034
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), By
  1. Type, Value (USD Million), Volume (Million Units)
    1. Prescription Medicines
    2. OTC Medicines
  2. End user, Value (USD Million)
    1. Hospital Pharmacies
    2. Drug Stores and Retail Pharmacies
    3. Online Providers
Global Economic Scenario
1. World Economic Outlook
About Research Nester
1. Our Global Clientele
2. We Serve Clients Across World

Companies Dominating the U.S. Lidocaine Patches Landscape

The U.S. lidocaine patches market is highly competitive, comprising key players such as Amneal Pharmaceuticals LLC, Hisamitsu America, Inc., Scilex Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., and YARAL Pharma Inc., which, through their contributions, drive the growth of the segment. Major players in this market invest significantly in research and development to bring about new and innovative products to meet the growing demand for effective and non-opioid pain management solutions. Their strategies have been the development of portfolios to address a range of pain conditions and building robust distribution networks. With the growing demand for localized pain relief options, these companies are further solidifying their market positions through strategic partnerships, acquisitions, and directed marketing efforts.

In June 2023, Huons Co. obtained FDA approval for the 2% lidocaine injection, a significant achievement in its development in the U.S. lidocaine patches market. While this regulatory success is based on injectable solutions, Huons demonstrates the potential for diversification into lidocaine patch offerings. Such approval indicates that the company meets the highest U.S. standards and positions it as competitive in the field of localized pain management. Furthermore, this points to a wider trend that highlights global companies are beginning to see the U.S. as a prime target market for advanced pain relief solutions.

Here are some leading companies in the U.S. lidocaine patches market:

Amneal Pharmaceuticals LLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Endo Pharmaceuticals Inc
Hisamitsu America, Inc.
Medline Industries, LP.
Scilex Pharmaceuticals Inc.
Sparsha Pharma USA
Teikoku Pharma
Teva Pharmaceuticals USA, Inc.
Viatris Inc.
YARAL Pharma Inc.Technology Analysis

Browse Key Market Insights with Data Illustration:

U.S. Lidocaine Patches Market Size, Forecast Report 2034

In the News

In October 2024, Hisamitsu Pharmaceutical initiated clinical trials for HP-3150, a diclofenac sodium transdermal patch, targeting chronic lower back pain in the U.S. While not a direct lidocaine product, this innovation highlights the expanding demand for transdermal pain relief technologies and complements existing lidocaine patch applications.
In May 2024, Teikoku Pharma USA (TPU) secured Chinese regulatory approval for Lidoderm, its 5% lidocaine patch, for Post Herpetic Neuralgia (PHN). This international milestone underscores the therapeutic versatility of lidocaine patches and reinforces their growing role in addressing chronic pain conditions in the U.S. market.
In September 2023, Yaral Pharma Inc. expanded its portfolio with the launch of lidocaine patch 5%, an AB-rated alternative to Lidoderm. This introduction caters to the increasing need for prescription-strength, non-opioid pain relief options in the U.S., bolstering Yaral Pharma’s position in the lidocaine patch market.

Frequently Asked Questions (FAQ)

In 2024, the industry size of U.S. lidocaine patch was USD 560.7 million.

The U.S. lidocaine patch market size was USD 560.7 million in 2024 and is expected to reach USD 963 million by the end of 2034, expanding at a CAGR of 5.5% during the forecast period, i.e., 2025-2034. In 2025, the industry size of U.S. lidocaine patch will be valued at USD 591.2 million.

Key players in the market are Amneal Pharmaceuticals LLC, Endo Pharmaceuticals Inc, Hisamitsu America, Inc., Medline Industries, LP., Scilex Pharmaceuticals Inc., Sparsha Pharma USA, Teikoku Pharma, Teva Pharmaceuticals USA, Inc., Viatris Inc., YARAL Pharma Inc.

The prescription medicines segment is anticipated to lead the U.S. lidocaine patch market during the forecast period.

Southeast U.S. is likely to offer lucrative prospects to the companies in market during the forecast period.

United States Lidocaine Patches Market - Top Companies and Manufacturers

Companies Dominating the U.S. Lidocaine Patches Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the U.S. lidocaine patches industry?

What is the outlook for the U.S. lidocaine patches market?

Who are the major players dominating the U.S. lidocaine patches landscape?

Which segment will capture the significant market share for U.S. lidocaine patches by 2034?

Which region will provide more opportunities for the U.S. lidocaine patches business in the coming years?